Feng-shou Ko

Available identifiers

zbMath Open ko.feng-shouWikidataQ102426194 ScholiaQ102426194MaRDI QIDQ2807713

List of research outcomes

Publication	Date of Publication	Type
The Simon’s two-stage design accounting for genetic heterogeneity	2024-05-17	Paper
Comparisons of a multi-regional trial for four or five regions by fixed effect model and random effect model about allocating sample size rationally into individual regions for a multi-regional trial	2023-11-17	Paper
An issue about the efficacy for the time-to-event outcome based on accelerated failure time model with interaction of unrecognized heterogeneity and main effect	2023-02-03	Paper
The issue about sample size for survival analysis considering the interaction of unrecognized heterogeneity and treatment	2022-09-14	Paper
An approach to use of an adaptive procedure to clinical trials for molecularly heterogenous subject selection at interim	2022-06-27	Paper
An alternate approach for sample size determination in a multi-regional trial	2022-06-27	Paper
How the mechanism of missing data on longitudinal biomarkers influences the survival analysis	2022-05-20	Paper
Discussion on the issue of sample size determination for a targeted to an untargeted and to a mixed effect model-based clinical trial design	2022-02-23	Paper
Application of trajectories from growth curve in identification of longitudinal biomarker for the multivariate survival data	2020-12-04	Paper
Evaluate the relative efficiency of a targeted clinical trial design to an untargeted design under the issue of cost	2018-03-07	Paper
Identification of longitudinal biomarkers for survival by a score test derived from a joint model of longitudinal and competing risks data	2017-01-04	Paper
Comparisons of allocating sample size rationally into individual regions under heterogeneous effect size in a multiregional trial by a fixed effect model and a random effect model	2016-11-23	Paper
Sample size determination for quality control process using a multiple components tolerance interval	2016-07-15	Paper
The method to identify a biomarker and to evaluate its efficiency for survival by using the joint model of the accelerate failure time and longitudinal data	2016-06-28	Paper
Identification of potential longitudinal biomarkers under the accelerated failure time model in multivariate survival data	2016-05-25	Paper
A statistical issue about a phase III multi-regional trial for the survival data under accelerated failure time model with unrecognized heterogeneity	2016-01-05	Paper
Sample Size Determination and Rational Partition for A Multi- Regional Trial for Survival (Time-To-Event) Data with Unrecognized Heterogeneity that Interacts with Treatment	2015-04-29	Paper
Sample size determination for a two-sided multiple components tolerance interval	2015-03-13	Paper
An approach to determine sample size and to allocate sample size for a specific region in a multiregional trial for survival (time-to-event) data under accelerated failure time model	2015-03-13	Paper
Identification of longitudinal biomarkers in survival analysis for competing risks data	2014-11-26	Paper
A design for survival studies: A multi-regional trial with unrecognized heterogeneity	2013-11-07	Paper
Approaches to allocate sample size rationally into individual regions for a multi-regional trial under heterogeneous effect size	2012-11-12	Paper
The identification of potential longitudinal biomarkers and measurements of effectiveness for biomarkers as surrogates in multivariate survival data	2012-10-23	Paper
Using the Score Test to Identify the Longitudinal Biomarker Considering Accelerate Failure Time Model with the Frailty in Survival Analysis	2012-06-08	Paper
Detecting outliers in large medical records: using a frontier model	2011-07-20	Paper
Using Frailty Models to Identify the Longitudinal Biomarkers in Survival Analysis	2010-12-20	Paper

Research outcomes over time

This page was built for person: Feng-shou Ko